[3P-858_3SP-10-06] NF-kB is a potential therapeutic target for histone deacetylase inhibitor-resistant cutaneous T-cell lymphoma.

^○Yuto Takahashi¹, Akihiro Kitadate², Sho Ikeda², Sayaka Iwama¹, Ko Abe², Wataru Kuroki², Masahiro Yamada², Hiroyuki Tagawa², Hideki Wakui¹, Naoto Takahashi² (1.Dept. of Life Sci., Grad. Sch. of Eng. Sci., Univ. of Akita, 2.Dept. of Hematology, Nephrology, and Rheumatology, Grad. Sch. of Med., Univ. of Akita)